Gerardo Hernandez - 09 Dec 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Chief Financial Officer
Signature: By: /s/ Waleed Hassanein, M.D., Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 09 Dec 2024
Transactions value $: $0
Form type: 4
Filing time: 11 Dec 2024, 18:48:56 UTC
Previous filing: 02 Dec 2024
Next filing: 26 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Award	$0	+12.5K		$0.00	12.5K	09 Dec 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Award	$0	+18.9K		$0.00	18.9K	09 Dec 2024	Common Stock	18.9K	$69.84	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 12,463 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2	The option vests as to 25% of the shares underlying the option on December 2, 2025 and as to the remaining shares in equal monthly installments over three years thereafter, subject to Reporting Persons' continued service to the Issuer.